I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Stroyakovskiy, Daniil
61
results:
Search for persons
X
Format
Online (61)
Mediatypes
Articles (Online) (23)
OpenAccess-fulltext (38)
Languages
english (44)
russian (5)
Sorted by: Relevance
Sorted by: Year
?
1
Plain language summary of SUNLIGHT: trifluridine/tipiracil ..:
Prager, Gerald W
;
Taieb, Julien
;
Fakih, Marwan
...
Future Oncology. , 2024
Link:
https://doi.org/10.1080/..
?
2
Safety and efficacy of ribociclib in combination with letro..:
Zhukova, Liudmila G.
;
Bolotina, Larisa V.
;
Dvornichenko, Victoria V.
...
Journal of Modern Oncology. 26 (2024) 1 - p. 56-64 , 2024
Link:
https://doi.org/10.26442..
?
3
Health-Related Quality of Life Outcomes With Two Different ..:
Bergerot, Cristiane
;
Young Rha, Sun
;
Pal, Sumanta
...
The Oncologist. 28 (2023) 1 - p. 59-71 , 2023
Link:
https://doi.org/10.1093/..
?
4
Overall survival with first-line atezolizumab in combinatio..:
Ascierto, Paolo A
;
Stroyakovskiy, Daniil
;
Gogas, Helen
...
The Lancet Oncology. 24 (2023) 1 - p. 33-44 , 2023
Link:
https://doi.org/10.1016/..
?
5
Rationale and trial design of NATALEE: a Phase III trial of..:
Slamon, Dennis J.
;
Fasching, Peter A.
;
Hurvitz, Sara
...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023
Link:
https://doi.org/10.1177/..
?
6
Efficacy and safety of nurulimab+prolgolimab with continued..:
Samoylenko, Igor V.
;
Demidov, Lev V.
;
Moiseenko, Fedor V.
...
Journal of Modern Oncology. 25 (2023) 3 - p. 313-324 , 2023
Link:
https://doi.org/10.26442..
?
7
Randomized double-blind clinical trial comparing safety and..:
Stroyakovskiy, Daniil L.
;
Fadeeva, Natalya V.
;
Matrosova, Marina P.
...
BMC Cancer. 22 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
8
IMpower150 Final Exploratory Analyses for Atezolizumab Plus..:
Nogami, Naoyuki
;
Barlesi, Fabrice
;
Socinski, Mark A.
...
Journal of Thoracic Oncology. 17 (2022) 2 - p. 309-323 , 2022
Link:
https://doi.org/10.1016/..
?
9
Assessing the Safety and Efficacy of Two Starting Doses of ..:
Pal, Sumanta K.
;
Puente, Javier
;
Heng, Daniel Y.C.
...
European Urology. 82 (2022) 3 - p. 283-292 , 2022
Link:
https://doi.org/10.1016/..
?
10
Crossover and rechallenge with pembrolizumab in recurrent p..:
Eggermont, Alexander MM.
;
Meshcheryakov, Andrey
;
Atkinson, Victoria
...
European Journal of Cancer. 158 (2021) - p. 156-168 , 2021
Link:
https://doi.org/10.1016/..
?
11
Ipatasertib plus abiraterone and prednisolone in metastatic..:
Sweeney, Christopher
;
Bracarda, Sergio
;
Sternberg, Cora N
...
The Lancet. 398 (2021) 10295 - p. 131-142 , 2021
Link:
https://doi.org/10.1016/..
?
12
Multicenter prospective observational post-approval study o..:
Tryakin, Alexey A.
;
Fedyanin, Mikhail Yu.
;
Moiseenko, Fedor V.
...
Journal of Modern Oncology. 23 (2021) 4 - p. 695-702 , 2021
Link:
https://doi.org/10.26442..
?
13
Real-World Experience with Targeted Therapy in BRAF Mutant ..:
Orlova, Kristina V.
;
Ledin, Evgeniy V.
;
Zhukova, Natalia V.
...
Cancers. 13 (2021) 11 - p. 2529 , 2021
Link:
https://doi.org/10.3390/..
?
14
5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV6..:
Ascierto, Paolo A.
;
Dréno, Brigitte
;
Larkin, James
...
Clinical Cancer Research. 27 (2021) 19 - p. 5225-5235 , 2021
Link:
https://doi.org/10.1158/..
?
15
IMpower150 Final Overall Survival Analyses for Atezolizumab..:
Socinski, Mark A.
;
Nishio, Makoto
;
Jotte, Robert M.
...
Journal of Thoracic Oncology. 16 (2021) 11 - p. 1909-1924 , 2021
Link:
https://doi.org/10.1016/..
1-15